BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22461294)

  • 1. Pharmaco-economic issues in the treatment of severe osteoporosis.
    Piscitelli P; Chitano G; Greco M; Benvenuto M; Sbenaglia E; Colì G; Migliore A; Granata M; Iolascon G; Gimigliano R; Baggiani A; Distante A; Tarantino U; Rizzuti C; Brandi ML
    Clin Cases Miner Bone Metab; 2010 Jan; 7(1):61-4. PubMed ID: 22461294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the TARGET project.
    Piscitelli P; Metozzi A; Brandi ML; Nuti R; Rizzuti C; Orlandini E; Giorni L; Merlotti D
    Clin Cases Miner Bone Metab; 2010 May; 7(2):140-3. PubMed ID: 22460020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TARGET project in Tuscany: the first disease management model of a regional project for the prevention of hip re-fractures in the elderly.
    Piscitelli P; Brandi ML; Nuti R; Rizzuti C; Giorni L; Giovannini V; Metozzi A; Merlotti D
    Clin Cases Miner Bone Metab; 2010 Sep; 7(3):251-4. PubMed ID: 22460536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and costs of hip fractures in elderly Italian population: first regional-based assessment.
    Piscitelli P; Feola M; Rao C; Neglia C; Rizzo E; Vigilanza A; Rivezzi M; Faccilongo N; Contò F; Distante A; Tarantino U
    Arch Osteoporos; 2019 Jul; 14(1):81. PubMed ID: 31342284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and economic burden of osteoporosis in Switzerland.
    Svedbom A; Ivergård M; Hernlund E; Rizzoli R; Kanis JA
    Arch Osteoporos; 2014; 9():187. PubMed ID: 24970672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifracture drugs consumption in Tuscany Region before the Target Project: a valuable model for the analysis of administrative database.
    Piscitelli P; Parri S; Brandi ML
    Clin Cases Miner Bone Metab; 2012 May; 9(2):76-9. PubMed ID: 23087714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of vertebral fragility fractures: can radiologists help reduce the number of hip fractures?
    Mitchell RM; Jewell P; Javaid MK; McKean D; Ostlere SJ
    Arch Osteoporos; 2017 Dec; 12(1):71. PubMed ID: 28785996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M; Davis S; Lloyd-Jones M; Beverley C
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
    Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
    Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in hip and distal femoral fracture rates in Italy from 2007 to 2017.
    Unim B; Minelli G; Da Cas R; Manno V; Trotta F; Palmieri L; Galluzzo L; Maggi S; Onder G
    Bone; 2021 Jan; 142():115752. PubMed ID: 33188958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study.
    Tarantino U; Capone A; Planta M; D'Arienzo M; Letizia Mauro G; Impagliazzo A; Formica A; Pallotta F; Patella V; Spinarelli A; Pazzaglia U; Zarattini G; Roselli M; Montanari G; Sessa G; Privitera M; Verdoia C; Corradini C; Feola M; Padolino A; Saturnino L; Scialdoni A; Rao C; Iolascon G; Brandi ML; Piscitelli P
    Arthritis Res Ther; 2010; 12(6):R226. PubMed ID: 21190571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
    Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
    Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated incidence rates of fragility fractures in Italy: extension study 2002-2008.
    Piscitelli P; Tarantino U; Chitano G; Argentiero A; Neglia C; Agnello N; Saturnino L; Feola M; Celi M; Raho C; Distante A; Brandi ML
    Clin Cases Miner Bone Metab; 2011 Sep; 8(3):54-61. PubMed ID: 22461831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
    Gonnelli S; Caffarelli C; Iolascon G; Bertoldo F; Letizia Mauro G; Patti A; Nuti R
    Aging Clin Exp Res; 2017 Oct; 29(5):1031-1037. PubMed ID: 27943127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of fragility fractures in Italy.
    Ratti C; Vulcano E; La Barbera G; Canton G; Murena L; Cherubino P
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S13-4. PubMed ID: 24046040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
    Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
    Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs.
    Sander B; Elliot-Gibson V; Beaton DE; Bogoch ER; Maetzel A
    J Bone Joint Surg Am; 2008 Jun; 90(6):1197-205. PubMed ID: 18519311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.